Quality Assurance in Cytopathology — MCQs
Specificity of a diagnostic test is defined as:
Which of the following attributes are essential for an ideal screening test?
Arrange the following in sequential order with regards to the steps of collection of samples for pap smear testing: Use posterior vaginal wall retractor Take the sample Make smear on a slide Fix the smear
Which of the following statements about nucleic acid amplification tests (NAATs) for STIs is FALSE?
In a screening test for DM out of 1000 population, 90 were positive. When the gold standard test was applied to the entire population, 100 were found to have the disease. Assuming all 90 screening positives were confirmed as true positives by the gold standard, calculate the sensitivity.
Which of the following thyroid carcinomas cannot be definitively diagnosed by fine needle aspiration cytology (FNAC)?
In which context are leading questions allowed?
Which of the following organizations is recognized for establishing guidelines for antimicrobial susceptibility testing?
Name the cells marked as X in Pap smear.
Which of the following stains is NOT used for the detection of fat?
Quality Assurance in Cytopathology Indian Medical PG Practice Questions and MCQs
Question 1: Specificity of a diagnostic test is defined as:
- A. 0.95 (Correct Answer)
- B. 0.05
- C. 0.4
- D. 0.8
Explanation: ***0.95*** - **Specificity** is the proportion of individuals without disease who test negative, calculated as **TN/(TN+FP)**. - A specificity of 0.95 (95%) indicates an excellent test that correctly identifies 95% of healthy individuals as negative. *0.05* - This value represents the **false positive rate** (1 - specificity), not specificity itself. - A specificity of 0.05 would mean only 5% of healthy individuals test negative, indicating a very poor test. *0.4* - This value is too low for specificity and could represent other test parameters like **positive predictive value**. - A specificity of 0.4 would incorrectly classify 60% of healthy individuals as positive, making the test clinically unreliable. *0.8* - This value typically represents **sensitivity**, which is the proportion of diseased individuals who test positive. - **Sensitivity** is calculated as **TP/(TP+FN)**, which is different from specificity that focuses on healthy individuals.
Question 2: Which of the following attributes are essential for an ideal screening test?
- A. Safe
- B. Reliable
- C. Valid
- D. All of the options (Correct Answer)
Explanation: ***All of the options*** - An ideal screening test must possess **all three essential attributes**: safety, reliability, and validity. - **Safe**: Minimizes harm to participants and ensures ethical implementation - **Reliable**: Produces consistent, reproducible results with minimal random error - **Valid**: Accurately measures what it intends to measure (high sensitivity and specificity) - These three attributes work together as fundamental requirements for any effective screening program, ensuring that early detection benefits outweigh potential risks. *Safe (alone)* - While safety is absolutely essential, it is **not sufficient by itself** to make an ideal screening test. - A test that is safe but unreliable or invalid would produce inconsistent or inaccurate results, rendering it ineffective for screening purposes. *Reliable (alone)* - Reliability ensures consistent results, which is crucial, but **reliability alone is insufficient**. - A test can be highly reliable (consistently giving the same result) yet completely invalid if it measures the wrong thing or is unsafe. *Valid (alone)* - Validity is critical for accurate measurement, but **validity alone does not make a test ideal**. - Even a valid test must be safe to protect participants and reliable to ensure consistency across different settings and times.
Question 3: Arrange the following in sequential order with regards to the steps of collection of samples for pap smear testing: Use posterior vaginal wall retractor Take the sample Make smear on a slide Fix the smear
- A. 1,2,4,3
- B. 3,1,2,4
- C. 1,2,3,4 (Correct Answer)
- D. 2,1,3,4
Explanation: ***1,2,3,4*** - The correct sequence for collecting a Pap smear involves first **visualizing the cervix** using a posterior vaginal wall retractor, then **taking the sample** (e.g., using a broom or spatula and brush), followed by **making a smear on a slide** and finally **fixing the smear** to preserve the cells. - This sequential order ensures proper cell collection and preservation for accurate cytological examination. *1,2,4,3* - This option incorrectly places **fixing the smear** before **making the smear on the slide**. Cells must first be spread onto the slide before they can be fixed. - Fixing an un-smeared sample or attempting to smear after fixing would lead to an inadequate or damaged specimen. *3,1,2,4* - This sequence incorrectly starts with **making a smear on a slide** before any sample has been collected or the cervix visualized. - One cannot make a smear without first taking a sample and accessing the cervix via a retractor. *2,1,3,4* - This option incorrectly states that **taking the sample** occurs before **using a posterior vaginal wall retractor**. The retractor is essential for proper visualization and access to the cervix to obtain a quality sample. - Attempting to take a sample without proper visualization would lead to an inadequate or incorrect specimen collection.
Question 4: Which of the following statements about nucleic acid amplification tests (NAATs) for STIs is FALSE?
- A. They can be used for test of cure after 3 weeks
- B. They can detect dead organisms after treatment
- C. They can be used for pharyngeal gonorrhea screening
- D. They are less sensitive than culture for rectal chlamydia (Correct Answer)
Explanation: ***They are less sensitive than culture for rectal chlamydia*** - This statement is **FALSE**. NAATs are generally **more sensitive** than culture methods for detecting *Chlamydia trachomatis* in all anatomical sites, including the rectum. - The high sensitivity of NAATs allows for the detection of very low bacterial loads, making them the preferred diagnostic method for many STIs. *They can be used for test of cure after 3 weeks* - This statement is generally **true**. While a "test of cure" (TOC) is not routinely recommended for uncomplicated *Chlamydia* or *Gonorrhea* infections due to high treatment efficacy, it can be considered in specific circumstances (e.g., persistent symptoms, pregnancy, or use of alternative regimens). - If a TOC is performed, it should ideally be done **no sooner than 3 weeks post-treatment** to minimize potential false positives from detecting residual nucleic acids from dead organisms. *They can detect dead organisms after treatment* - This statement is **true**. NAATs detect the **nucleic acids (DNA or RNA)** of the target organism. - These nucleic acids can persist in the body for a period even after the organism has been killed by treatment, leading to a positive NAAT result despite successful eradication of the infection. *They can be used for pharyngeal gonorrhea screening* - This statement is **true**. NAATs are the **recommended method** for detecting *Neisseria gonorrhoeae* in extragenital sites, including the pharynx. - Pharyngeal gonorrhea is often **asymptomatic**, making screening of at-risk individuals important for public health.
Question 5: In a screening test for DM out of 1000 population, 90 were positive. When the gold standard test was applied to the entire population, 100 were found to have the disease. Assuming all 90 screening positives were confirmed as true positives by the gold standard, calculate the sensitivity.
- A. All positives identified by the test assumed as true positives (100%)
- B. True positives divided by total actual positives (90%) (Correct Answer)
- C. Underestimated true positives divided by total actual positives (80%)
- D. Total positives identified by the test divided by total actual positives (90%)
Explanation: ***True positives divided by total actual positives (90%)*** - **Sensitivity** is the proportion of true positives correctly identified by a screening test among all individuals who actually have the disease. It is calculated by (Number of True Positives) / (Total Number of Diseased Individuals). - In this case, 90 people screened positive and were confirmed as **true positives**. The total number of people with the disease (actual positives) is 100. So, sensitivity = 90/100 = **90%**. *Total positives identified by the test divided by total actual positives (90%)* - While this option states the correct percentage (90%), the phrasing "total positives identified by the test" is misleading terminology. In screening test evaluation, this could be confused with all test positives (which would include false positives if they existed). - The correct terminology is "true positives" divided by "total actual positives," not "total positives identified by the test." The distinction is important: true positives are confirmed cases, while test positives might include false positives. *All positives identified by the test assumed as true positives (100%)* - This option incorrectly assumes that because all 90 screening positives were confirmed as true positives, the sensitivity must be 100%. However, sensitivity measures how many of ALL diseased individuals were caught, not just those who screened positive. - There were 100 actual diseased individuals, and only 90 were identified by the screening test; therefore, the sensitivity cannot be 100%. The test missed 10 diseased individuals (false negatives). *Underestimated true positives divided by total actual positives (80%)* - This option presents an arbitrary percentage that does not reflect the given data. There is no information to suggest that the true positives were underestimated or that the calculation would result in 80%. - The actual number of true positives (90) and actual positives (100) directly leads to a sensitivity calculation of 90%, not 80%.
Question 6: Which of the following thyroid carcinomas cannot be definitively diagnosed by fine needle aspiration cytology (FNAC)?
- A. Anaplastic carcinoma of thyroid
- B. Medullary carcinoma of thyroid
- C. Follicular carcinoma of thyroid (Correct Answer)
- D. Papillary carcinoma of thyroid
Explanation: ***Follicular carcinoma of thyroid*** - The definitive diagnosis of **follicular carcinoma** requires the presence of **capsular or vascular invasion**, which cannot be assessed through **fine needle aspiration cytology (FNAC)** alone [1], [5]. - FNA may show features suggestive of follicular neoplasm (e.g., hypercellularity with microfollicles), but differentiation from **follicular adenoma** requires histological examination of the excised specimen [1], [4]. *Anaplastic carcinoma of thyroid* - **Anaplastic carcinoma** is highly aggressive and characterized by **pleomorphic, bizarre cells** that are easily identifiable on FNAC [2], [5]. - The distinctive cytological features, including **spindle cells, giant cells, and rapid cellular atypia**, allow for a relatively straightforward diagnosis via FNAC [2]. *Medullary carcinoma of thyroid* - **Medullary carcinoma** cells have characteristic cytological features, such as **plasmacytoid appearance**, **amyloid deposition**, and **neuroendocrine granules**, which can be identified on FNAC [5]. - Confirmation can be made by **immunohistochemical staining for calcitonin** on the FNA sample [5]. *Papillary carcinoma of thyroid* - **Papillary carcinoma** has distinct cytological features, including **orphan Annie eye nuclei**, **intranuclear grooves**, **pseudoinclusions**, and **papillary structures**, readily identified by FNAC [3]. - These features are highly specific and often allow for a definitive diagnosis of papillary thyroid carcinoma [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1100-1101. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1101-1102. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 429-430. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 428-429. [5] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 430-431.
Question 7: In which context are leading questions allowed?
- A. Cross-examination (Correct Answer)
- B. Direct examination
- C. Re-examination
- D. Dying declaration
Explanation: ***Cross-examination*** - Leading questions are permissible during **cross-examination** to challenge the witness's testimony and test credibility. - The purpose is to **elicit specific details**, confirm facts, or highlight inconsistencies in prior statements. *Direct examination* - Leading questions are **generally not allowed** during direct examination because it is the phase where a party questions its own witness. - The goal is for the witness to provide testimony in their **own words**, without suggestions from the attorney. *Re-examination* - Leading questions are **not allowed** during re-examination, which occurs after cross-examination to clarify points raised. - The scope of re-examination is **limited to the matters** brought up during cross-examination, and leading questions would be inappropriate. *Dying declaration* - A dying declaration is a statement made by a person who believes they are about to die, concerning the cause of their death. - The admissibility of a dying declaration as evidence is an **exception to the hearsay rule** and does not involve questioning by attorneys in a formal court setting at the time the declaration is made.
Question 8: Which of the following organizations is recognized for establishing guidelines for antimicrobial susceptibility testing?
- A. NCTC
- B. ATCC
- C. NCCLS (Correct Answer)
- D. EUCAST
Explanation: ***NCCLS*** - The **National Committee for Clinical Laboratory Standards (NCCLS)**, now known as the **Clinical and Laboratory Standards Institute (CLSI)**, is the primary organization that develops and publishes **standards and guidelines** for antimicrobial susceptibility testing. - These guidelines are crucial for ensuring the **accuracy, reproducibility, and standardization** of antimicrobial susceptibility test results in clinical microbiology laboratories worldwide. *NCTC* - The **National Collection of Type Cultures (NCTC)** is a UK-based collection that provides a wide range of **bacterial strains** for research, identification, and quality control purposes. - While it supplies important reference strains, it does not primarily establish the **methodological guidelines** for susceptibility testing. *ATCC* - The **American Type Culture Collection (ATCC)** is a global non-profit organization that meticulously collects, authenticates, preserves, and distributes diverse **biological materials**, including microbial strains, cell lines, and other essential biomaterials, which are indispensable for global research and development. - While **ATCC strains** are used to validate susceptibility tests, ATCC itself does not develop the **testing guidelines**. *EUCAST* - The **European Committee on Antimicrobial Susceptibility Testing (EUCAST)** is a European organization that develops and publishes guidelines for antimicrobial susceptibility testing used primarily in Europe. - While EUCAST is an important guideline-setting body, **NCCLS/CLSI** is more widely recognized internationally and is the standard reference for most clinical laboratories globally, especially in the context of Indian medical examinations.
Question 9: Name the cells marked as X in Pap smear.
- A. Superficial cells (Correct Answer)
- B. Intermediate cells
- C. Para-basal cells
- D. Basal cells
Explanation: ***Superficial cells*** - These cells are characterized by a **small, pyknotic nucleus** and abundant, clear cytoplasm, which is typical for the cells marked as X in a Pap smear [1]. - They are the most mature cells of the vaginal epithelium and are prominent in the **proliferative phase** of the menstrual cycle. *Intermediate cells* - These cells have a **larger, vesicular nucleus** compared to superficial cells and a more folded cytoplasm. - They are more prominent during the **luteal phase** and pregnancy due to progesterone influence. *Para-basal cells* - These cells are smaller with a **larger nucleus-to-cytoplasm ratio** and are typically seen in atrophic smears or in children and postmenopausal women. - They represent the **immature cells** of the vaginal epithelium. *Basal cells* - These are the **deepest layer** of the squamous epithelium and are rarely seen in a normal Pap smear unless there is significant epithelial damage or sampling from deeper layers. - They have a **large nucleus** and very little cytoplasm. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, p. 1010.
Question 10: Which of the following stains is NOT used for the detection of fat?
- A. Oil red O
- B. Sudan black B
- C. Sudan III
- D. Congo red (Correct Answer)
Explanation: **Explanation:** The detection of lipids (fats) in histopathology requires specific stains that are more soluble in the lipid itself than in the solvent in which they are prepared. **Why Congo Red is the correct answer:** **Congo red** is the gold standard stain for **Amyloid**, not fat [1]. When viewed under polarized microscopy, amyloid stained with Congo red exhibits a characteristic **apple-green birefringence** [2]. It binds to the beta-pleated sheet structure of amyloid fibrils [2]. **Why the other options are incorrect:** * **Oil Red O:** This is the most commonly used stain for demonstrating neutral lipids and cholesterols in frozen sections. It imparts a bright red/orange color to fat droplets. * **Sudan Black B:** This is a lipophilic stain that stains neutral triglycerides and lipids black. It is also frequently used in hematopathology to differentiate Acute Myeloid Leukemia (AML) from Acute Lymphoblastic Leukemia (ALL), as it stains the phospholipid membranes of azurophilic granules. * **Sudan III:** Similar to Sudan IV and Oil Red O, this is a lysochrome (fat-soluble dye) used to identify triglycerides in sections or fecal fat analysis. **High-Yield Clinical Pearls for NEET-PG:** 1. **Processing Requirement:** To demonstrate fat, one must use **frozen sections** [3]. Routine processing (paraffin embedding) involves alcohols and xylenes which dissolve lipids, leaving behind empty vacuoles. 2. **Osmium Tetroxide:** This is another reagent used for fat; it fixes and stains lipids black, and unlike the others, it can be used in paraffin-embedded tissues. 3. **Amyloid Confirmation:** Remember the "ABCD" of Amyloid: **A**morphous, **B**eta-pleated, **C**ongo red positive, **D**ichroism (Birefringence). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Heart, pp. 580-581. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 268-269. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 25-26.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free